MENU

Click here to

×

Are you sure ?

Yes, do it No, cancel

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # | show all

Keywords: rbe
BReP-SNAP-T-16A Probabilistic Poisson Model to Determine RBE Changes Facilitates LET-Based Optimization in Intensity Modulated Proton Treatment
M Brooke*, A Vella, F Van den Heuvel, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, GB
MO-CD-TRACK 1-3Multi-Ion Therapy: Development, Validation and Clinical Direction of a Novel Particle Treatment Modality
S Mein1,2*, B Kopp1,2, I Dokic1,2, S Harrabi1, TT Boehlen3, T Haberer1, J Debus1,2, A Abdollahi1,2, A Mairani1,4 (1) Heidelberg Ion-beam Therapy Center (HIT), Heidelberg, DE, (2) German Cancer Research Center (DKFZ), Heidelberg, DE, (3) Center for Proton Therapy, Paul Scherrer Institute (PSI), Villigen, Switzerland, (4) National Centre of Oncological Hadrontherapy (CNAO), Pavia, Italy
PO-GeP-T-103An LET-Based Cell Survival RBE Model for X-Rays and Gamma Radiation
O Vassiliev*, C Peterson, D Grosshans, R Mohan, UT MD Anderson Cancer Center, Houston, TX
PO-GeP-T-231Comparison of the REB Enhancement Owing to Iodine, Calculated by MKM and LEM
Y Chiang*, Chang Gung University, Guishan Dist, TAOTW,
PO-GeP-T-453Feasibility of Relating LETd Differences to Toxicity for Head & Neck Proton Therapy
D Wagenaar*, J Langendijk, A Van Der Schaaf, S Both, Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
PO-GeP-T-561LET Painting Through Proton Mono-Energetic Arc Therapy (PMAT) to Enhance Radiobiological Effectiveness
A Bertolet*, A Carabe, Hospital of the University of Pennsylvania, Philadelphia, PA
PO-GeP-T-579Microdosimetric Assessment of Model Based Relative Biological Effectiveness in Carbon Ion Therapy
S Hartzell*, F Guan, O Vassiliev, P Taylor, C Peterson, S Kry, The University of Texas MD Anderson Cancer Center, Houston, TX
PO-GeP-T-581MKM Versus Phenomenological Models for the Calculation of Proton RBE in Prostate Radiotherapy
A Bertolet*, A Carabe, Hospital of the University of Pennsylvania, Philadelphia, PA
PO-GeP-T-695RBE Calculation Using the Survival Simulation Tool for HSG, V79 and CHO Cells Irradiated by 12C, 20Ne and 3He Ions
M Suga1,3*, T Honma2, S Lee3, M Suzuki3, H Katou1, M Hashimoto2, K Tanimoto3, R Kohno3, (1) Kanagawa Cancer Center, Kanagawa, JP(2)International University of Health and Welfare Graduate school, Tochigi, JP(3)National Institute of Radio. Sciences, Chiba, JP
PO-GeP-T-712Robust Proton Plan Optimization Considering Geometrical and Biological Uncertainties
J Oden*, E Traneus, RaySearch Laboratories AB, Stockholm, SE
PO-GeP-T-728SLD Repair Impact On Treatment Effectiveness of Proton Therapy with Various Cell Specific Parameters
K Kasamatsu1*, T Matsuura2,3,4, S Tanaka2,4, K Umegaki2,3,4, (1) Hokkaido University Graduate school of Biomedical Science and Engineering, Sapporo, JP, (2) Hokkaido Universty Faculty of Engineering, Sapporo, Hokkaido, JP, (3) Hokkaido University Global Station for Quantum Medical Science and Engineering, Global Institution for Collaborative Research and Education (GI-CoRE), Sapporo, Hokkaido, JP, (4) Hokkaido University Hospital Proton Beam Therapy Center, Sapporo, Hokkaido, JP
PO-GeP-T-816Uncertainty Analysis for Relative Biological Effectiveness Derived From Different Dose-Effect Curve Model Fits
M Ghafarian*, J Eley, Vanderbilt University School of Medicine, Nashville, TN
TU-E-TRACK 5-0Mechanisms and Clinical Significance of Particle RBE
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-1An Introduction to the Problem of RBE in Particle Therapy
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-2Track-end objectives in intensity modulated proton therapy to reduce linear energy transfer
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-3Uncertainty and sensitivity analysis of biological modeling in proton and carbon ion treatment planning
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-4Proton Therapy and Variations in RBE - A Clinical Perspective
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
TU-E-TRACK 5-5Variable RBE (vRBE) Models are the Future of Particle Therapy Treatment Planning
D Carlson1*, J Oden2*, F Kamp3*, H Paganetti4*, R Stewart5*, (1) University of Pennsylvania, Philadelphia, PA, (2) RaySearch Laboratories AB, Stockholm, SE, (3) University Hospital, LMU Munich, Munich, BV, DE, (4) Massachusetts General Hospital, Boston, MA, (5) University of Washington, Seattle, WA
WE-B-TRACK 3-3INSPIRE: A Multi-Centric Study to Harmonize Linear Energy Transfer (LET) Calculations for Biological Assessments of Proton Therapy Plans
J Oden1, 2*, C Hahn3, A Vestergaard4, M Fuglsang Jensen4, O Sokol5, C Pardi6, F Bourhaleb6, A Leite7, L De Marzi7, C Rose8, K Kirkby8, E Smith8, M Merchant8, L Grzanka9, A Dasu10, A Luehr3, 11, (1) RaySearch Laboratories AB, Stockholm, SE, (2) Stockholm University, Stockholm, SE, (3) OncoRay, National Center for Radiation Research in Oncology, Dresden, DE, (4) Danish Centre For Particle Therapy, Aarhus, DK, (5) GSI Helmholtz Centre For Heavy Ion Research, Darmstadt, DE, (6) I-SEE (Internet-Simulation Evaluation, Envision), Torino, IT, (7) Institut Curie, Orsay, FR, (8) University of Manchester, Manchester, UK, (9) Institute of Nuclear Physics Polish Academy of Sciences, Krakow, PL, (10) The Skandion Clinic, Uppsala, SE, (11) Technical University Dortmund, Institute of Medical Physics, Dortmund, DE
WE-D-TRACK 3-6RBE for STING Immunogenic Signaling From Low LET X-Rays and High LET Neutrons
D Miles1,2*, N Cao2, T Pulliam2, S Cherny2, R Stewart2, G Moffitt2, G Sandison2, P Nghiem2, P Goff2, E Hatch3, K Stantz1, (1) Purdue Univ, West Lafayette, IN, (2) University of Washington, Seattle, WA,(3) Fred Hutchinson Cancer Research Center